SIKs
SIKs (salt-inducible kinases) are serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis and tumor suppression etc.
Products Related to SIKs(12)
- GC11719HG-9-91-01CAS: 1456858-58-4Purity: >99.00%
HG-9-91-01 is a salt-inducible kinases (SIK) inhibitor, inhibited SIK1, SIK2, SIK3 with IC50 values of 0.92nM, 6.5nM and 19.4nM, respectively.
- GC31645YKL-05-099CAS: 1936529-65-5Purity: >99.50%
YKL-05-099 is a highly selective small molecule inhibitor of salt-inducible kinases (SIK1: IC 50 = 10nM; SIK2: IC 50 = 40nM; SIK3: IC 50 = 20nM).
- GC37951YKL-06-061CAS: 2172617-15-9Purity: >99.00%
YKL-06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 values of 6.56 nM/1.77 nM/20.5 nM for SIK1/2/3, respectively.
- GC39148Pterosin BCAS: 34175-96-7Purity: >99.00%
Pterosin B, a indanone found in bracken fern (Pteridium aquilinum), is an inhibitor of salt-inducible kinase 3 (Sik3) signaling.
- GC39195YKL-06-062CAS: 2172617-16-0Purity: >98.00%
YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM, respectively.
- GC79425SK-124CAS: 2760404-50-8Purity: >95.00%
SK-124 is an orally active salt-inducible kinase ( SIK ) inhibitor with an IC 50 of 230 nM against SIK1, 4.1 nM against SIK2, and 21 nM against SIK3, exhibiting excellent kinome selectivity [1] [2] [4] . SK-124 blocks SIK-mediated CRTC2 phosphorylation, promotes CRTC2 nuclear translocation, and regulates vitamin D metabolism by upregulating renal Cyp27b1 and downregulating Cyp24a1 [1] [4] . SK-124 upregulates the expression of bone-related genes, increases serum Ca 2+, 1,25-vitamin D and intact FGF23 levels, and suppresses endogenous PTH levels [1] [2] [3] [4] . SK-124 can be used in studies related to osteoporosis, male osteoporosis, and chronic kidney disease-mineral and bone disorder [2] [3] [4] .
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11719 | HG-9-91-01 | 1456858-58-4 | >99.00% | |
HG-9-91-01 is a salt-inducible kinases (SIK) inhibitor, inhibited SIK1, SIK2, SIK3 with IC50 values of 0.92nM, 6.5nM and 19.4nM, respectively. | ||||
| GC31645 | YKL-05-099 | 1936529-65-5 | >99.50% | |
YKL-05-099 is a highly selective small molecule inhibitor of salt-inducible kinases (SIK1: IC 50 = 10nM; SIK2: IC 50 = 40nM; SIK3: IC 50 = 20nM). | ||||
| GC33070 | ARN-3236 | 1613710-01-2 | >99.50% | |
ARN-3236 is a selective salt-inducible kinase 2 (SIK2) inhibitor with an IC 50 of less than 1nM. ARN-3236 also inhibits the activity of SIK1 (IC 50 <21.63nM) and SIK3 (IC 50 <6.63nM). | ||||
| GC37951 | YKL-06-061 | 2172617-15-9 | >99.00% | |
YKL-06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 values of 6.56 nM/1.77 nM/20.5 nM for SIK1/2/3, respectively. | ||||
| GC39148 | Pterosin B | 34175-96-7 | >99.00% | |
Pterosin B, a indanone found in bracken fern (Pteridium aquilinum), is an inhibitor of salt-inducible kinase 3 (Sik3) signaling. | ||||
| GC39195 | YKL-06-062 | 2172617-16-0 | >98.00% | |
YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM, respectively. | ||||
| GC62142 | WH-4-025 | 1876463-35-2 | >98.50% | |
WH-4-025 is a Salt-inducible kinase (SIK) inhibitor (WO2016023014 A2). | ||||
| GC62657 | MRIA9 | 2750707-05-0 | >98.00% | |
MRIA9 is an ATP-competitive, pan Salt-Inducible kinase (SIK) and PAK2/3 inhibitor, with IC50 values of 516 nM, 180 nM and 127 nM for SIK1, SIK2 and SIK3, respectively. | ||||
| GC69169 | GLPG3970 | 2403733-82-2 | >98% | |
GLPG3970 (compound 88) is a novel SIK2/SIK3 inhibitor. GLPG3970 can be used for research on inflammation and autoimmune diseases. | ||||
| GC72915 | (R)-MRT199665 | - | >98.00% | |
(R)-MRT199665 is an isomer of MRT199665. | ||||
| GC73750 | GLPG3312 | 2340388-72-7 | >98.00% | |
GLPG3312 (Compound 28) is a selective pan-SIK inhibitor with IC50 values of 2.0 nM, 0.7 nM and 0.6 nM for SIK1, SIK2 and SIK3, respectively. | ||||
| GC79425 | SK-124 | 2760404-50-8 | >95.00% | |
SK-124 is an orally active salt-inducible kinase ( SIK ) inhibitor with an IC 50 of 230 nM against SIK1, 4.1 nM against SIK2, and 21 nM against SIK3, exhibiting excellent kinome selectivity [1] [2] [4] . SK-124 blocks SIK-mediated CRTC2 phosphorylation, promotes CRTC2 nuclear translocation, and regulates vitamin D metabolism by upregulating renal Cyp27b1 and downregulating Cyp24a1 [1] [4] . SK-124 upregulates the expression of bone-related genes, increases serum Ca 2+, 1,25-vitamin D and intact FGF23 levels, and suppresses endogenous PTH levels [1] [2] [3] [4] . SK-124 can be used in studies related to osteoporosis, male osteoporosis, and chronic kidney disease-mineral and bone disorder [2] [3] [4] . | ||||
